ArticleBone marrow transplantation2024

Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.

Giovanna Melica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.